Patent Yard Sign in
Expired Canadian patentCanada

Peptide amides, processes for the preparation thereof and agents containing these as fibrin/thrombin clotting inhibitors

CA 2042001 C · Owner: Behring Diagnostics Gmbh · Inventors: Stuber, Werner; Fickenscher, Karl

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Peptide amides of the formula I, GPRP-X-NR1-R2 I where G is the amino acid glycine, P is the amino acid L-proline, R is the amino acid L-arginine X is a, proteinogenous amino acid apart from proline or a dipeptide from these amino acids including proline N is, nitrogen and R1 and R2 are identical or different and are hydrogen or a lower alkyl chain having up to 4 carbon atoms; processes for the preparation thereof and the use thereof as medicament or for diagnostic purposes are described.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 7, 1991 and granted January 8, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 7, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 7, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 7, 1991
GrantedJanuary 8, 2002
Term endedMay 7, 2011
Patent numberCA 2042001 C
Classification (IPC)C07K7/06 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedMay 7, 1991Patent grantedJan 8, 2002Term endedMay 7, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.